• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pharmaceutical Industry Payments to Professional Medical Societies in Japan.日本制药行业向专业医学协会的付款。
J Gen Intern Med. 2024 Jun;39(8):1534-1535. doi: 10.1007/s11606-024-08735-5. Epub 2024 Mar 22.
2
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.制药公司向日本皮肤病学临床实践指南作者支付报酬的情况。
PLoS One. 2020 Oct 13;15(10):e0239610. doi: 10.1371/journal.pone.0239610. eCollection 2020.
3
Professional Medical Associations and Divestiture from Industry: An Ethical Imperative for Pain Society Leadership.专业医学协会与剥离行业利益：疼痛协会领导层的道德责任
Pain Med. 2016 Feb;17(2):218-9. doi: 10.1093/pm/pnv041_2.
4
Industry support and professional medical associations.行业支持与专业医学协会。
JAMA. 2009 Aug 19;302(7):738; author reply 739. doi: 10.1001/jama.2009.1194.
5
Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes.澳大利亚制药行业向专业医学协会领导人的支付情况：关注心血管疾病和糖尿病。
Aust J Gen Pract. 2020 Mar;49(3):151-154. doi: 10.31128/AJGP-08-19-5041.
6
Pain Medicine Ethics Forum: Key Opinion Leaders with Industry Conflicts of Interest Should Be Able to Hold Leadership Positions in Professional Medical Associations.疼痛医学伦理论坛：存在行业利益冲突的关键意见领袖应能够在专业医学协会中担任领导职务。
Pain Med. 2016 Feb;17(2):218. doi: 10.1093/pm/pnv041_1.
7
Industry support and professional medical associations.行业支持与专业医学协会。
JAMA. 2009 Aug 19;302(7):738-9; author reply 739. doi: 10.1001/jama.2009.1195.
8
Unease on industry's role in hypertension debate.对该行业在高血压辩论中所扮演角色的不安。
N Y Times Web. 2006 May 20:A1, C9.
9
Do drug firm links sway psychiatry?制药公司的关系会影响精神病学吗？
New Sci. 2006;190(2549):14.
10
Why the data diverge on the dangers of Vioxx: even in medical journals, statistics can be subject to broad interpretation.关于万络（Vioxx）危险性的数据为何存在分歧：即使在医学期刊中，统计数据也可能有多种宽泛的解读。
N Y Times Web. 2006 May 22:C1, C5.

引用本文的文献

1
Non-research payments to board-certified cardiologists from pharmaceutical industry in Japan from 2016 to 2019: a retrospective analysis.2016年至2019年日本制药行业向获得董事会认证的心脏病专家支付的非研究款项：一项回顾性分析。
BMJ Open. 2024 Jul 31;14(7):e083445. doi: 10.1136/bmjopen-2023-083445.

本文引用的文献

1
Medical royal colleges receive millions from drug and medical devices companies.医学皇家学院从制药和医疗器械公司获得数百万资金。
BMJ. 2023 Jul 26;382:1658. doi: 10.1136/bmj.p1658.
2
Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021.2014 年至 2021 年美国肾脏病学家的研究和非研究行业薪酬。
J Am Soc Nephrol. 2023 Oct 1;34(10):1709-1720. doi: 10.1681/ASN.0000000000000172. Epub 2023 Jul 25.
3
Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020.2016 年至 2020 年期间，日本制药公司与内科亚专业学会理事会成员之间的财务利益冲突。
J Eval Clin Pract. 2023 Sep;29(6):883-886. doi: 10.1111/jep.13877. Epub 2023 Jun 7.
4
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency.英国和日本制药行业支付披露的国际比较：对自我监管、公共监管和透明度的影响。
Global Health. 2023 Mar 3;19(1):14. doi: 10.1186/s12992-022-00902-9.
5
Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan.制药公司向日本专业医学协会执行委员会成员支付款项。
JAMA Intern Med. 2019 Apr 1;179(4):578-580. doi: 10.1001/jamainternmed.2018.7283.

Pharmaceutical Industry Payments to Professional Medical Societies in Japan.

作者信息

Murayama Anju, Higuchi Kenichi, Senoo Yuki

机构信息

School of Medicine, Tohoku University, Sendai City, Miyagi, Japan.

Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

J Gen Intern Med. 2024 Jun;39(8):1534-1535. doi: 10.1007/s11606-024-08735-5. Epub 2024 Mar 22.

DOI:10.1007/s11606-024-08735-5
PMID:38519746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11169125/
Abstract
摘要